ETF Holdings Breakdown of PCRX

News associated with PCRX

Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Average Recommendation of “Hold” by Brokerages

Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) have been assigned an average rating of “Hold” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating […] - 2025-06-18 08:08:55

Head to Head Analysis: Pacira BioSciences (NASDAQ:PCRX) versus I-Mab (NASDAQ:IMAB)

Pacira BioSciences (NASDAQ:PCRX – Get Free Report) and I-Mab (NASDAQ:IMAB – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings and analyst recommendations. Insider and Institutional Ownership 99.7% of Pacira BioSciences […] - 2025-06-18 06:08:45

California State Teachers Retirement System Has $812,000 Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)

California State Teachers Retirement System lessened its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 1.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 43,123 shares of the company’s stock after selling 835 shares during the quarter. California State Teachers […] - 2025-06-11 08:02:51

Two Sigma Investments LP Acquires 45,222 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)

Two Sigma Investments LP grew its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 65.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 114,682 shares of the company’s stock after buying an additional 45,222 shares during the quarter. Two Sigma Investments LP’s holdings in Pacira BioSciences were worth […] - 2025-06-02 08:08:57

State of Wyoming Boosts Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)

State of Wyoming lifted its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 8.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,566 shares of the company’s stock after purchasing an additional 487 shares during the quarter. State of Wyoming’s holdings […] - 2025-05-27 08:17:01

Graham Capital Management L.P. Sells 61,645 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)

Graham Capital Management L.P. decreased its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 83.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,268 shares of the company’s stock after selling 61,645 shares during the period. Graham Capital Management […] - 2025-05-19 08:27:01

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Voya Investment Management LLC

Voya Investment Management LLC lowered its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 68.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,948 shares of the company’s stock after selling 29,901 shares during the quarter. Voya Investment Management […] - 2025-05-13 08:20:57

MetLife Investment Management LLC Acquires 1,471 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)

MetLife Investment Management LLC grew its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 5.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 27,883 shares of the company’s stock after purchasing an additional 1,471 shares during the quarter. MetLife Investment Management LLC’s holdings in Pacira BioSciences were worth $525,000 as of […] - 2025-05-06 08:01:05

Marshall Wace LLP Has $803,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)

Marshall Wace LLP lessened its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 91.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 42,613 shares of the company’s stock after selling 482,336 shares during the period. Marshall Wace LLP’s holdings in […] - 2025-05-01 07:50:59

Legal & General Group Plc Sells 1,115 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)

Legal & General Group Plc decreased its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 0.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 125,849 shares of the company’s stock after selling 1,115 shares during the period. […] - 2025-04-25 08:08:57

Pacira BioSciences Announces Repurchase Authorization

(RTTNews) - Pacira BioSciences (PCRX) said its Board of Directors has authorized a share repurchase program of up to an aggregate of $300 million with respect to the common stock, replacing the prior authorization. The share repurchase authorization expires at the end of December - 2025-04-18 07:29:04

Sei Investments Co. Has $281,000 Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)

Sei Investments Co. trimmed its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 32.6% in the fourth quarter, HoldingsChannel reports. The firm owned 14,927 shares of the company’s stock after selling 7,231 shares during the period. Sei Investments Co.’s holdings in Pacira BioSciences were worth $281,000 as of its most recent SEC filing. […] - 2025-04-11 07:42:54

Wellington Management Group LLP Has $8.86 Million Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)

Wellington Management Group LLP lifted its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 3.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 470,191 shares of the company’s stock after purchasing an additional 15,542 shares during the quarter. Wellington Management Group LLP’s holdings in Pacira BioSciences were worth $8,858,000 […] - 2025-04-10 08:29:03

Pacira BioSciences (NASDAQ:PCRX) Shares Gap Up on Analyst Upgrade

Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) gapped up prior to trading on Tuesday after HC Wainwright raised their price target on the stock from $48.00 to $65.00. The stock had previously closed at $22.91, but opened at $27.60. HC Wainwright currently has a buy rating on the stock. Pacira BioSciences shares last traded […] - 2025-04-10 05:24:54

Corebridge Financial Inc. Reduces Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)

Corebridge Financial Inc. lowered its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 7.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 24,412 shares of the company’s stock after selling 1,904 shares during the period. Corebridge Financial Inc.’s holdings in Pacira BioSciences were worth $460,000 as of its most recent filing […] - 2025-04-09 08:27:01

Arrowstreet Capital Limited Partnership Sells 505,307 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)

Arrowstreet Capital Limited Partnership cut its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 43.8% during the 4th quarter, Holdings Channel.com reports. The fund owned 647,318 shares of the company’s stock after selling 505,307 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Pacira BioSciences were worth $12,195,000 as of […] - 2025-04-06 08:26:57

Thrivent Financial for Lutherans Has $672,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)

Thrivent Financial for Lutherans reduced its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 1.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 35,689 shares of the company’s stock after selling 534 shares during the period. Thrivent Financial for Lutherans’ holdings […] - 2025-04-03 07:16:46

Prudential Financial Inc. Decreases Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)

Prudential Financial Inc. reduced its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 42.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 254,168 shares of the company’s stock after selling 190,286 shares during the period. Prudential Financial Inc.’s holdings in Pacira BioSciences were worth $4,789,000 at the end of the most recent […] - 2025-04-01 08:34:48

Amundi Purchases 15,431 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)

Amundi raised its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 200.8% in the 4th quarter, Holdings Channel reports. The firm owned 23,114 shares of the company’s stock after buying an additional 15,431 shares during the period. Amundi’s holdings in Pacira BioSciences were worth $429,000 at the end of the most recent quarter. […] - 2025-03-21 07:59:07

Victory Capital Management Inc. Reduces Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)

Victory Capital Management Inc. trimmed its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 22.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 94,750 shares of the company’s stock after selling 27,478 shares during the quarter. Victory Capital […] - 2025-03-18 07:41:07

Illinois Municipal Retirement Fund Has $383,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)

Illinois Municipal Retirement Fund reduced its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 29.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,307 shares of the company’s stock after selling 8,510 shares during the period. […] - 2025-03-05 10:01:50

Principal Financial Group Inc. Has $4.86 Million Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)

Principal Financial Group Inc. boosted its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 4.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 257,733 shares of the company’s stock after buying an additional 10,306 shares during the quarter. Principal […] - 2025-03-04 08:14:50

Pacira BioSciences (NASDAQ:PCRX) Price Target Raised to $70.00 at HC Wainwright

Pacira BioSciences (NASDAQ:PCRX – Free Report) had its price target upped by HC Wainwright from $57.00 to $70.00 in a report published on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. Other research analysts have also recently issued research reports about the stock. Needham & Company LLC boosted their price objective […] - 2025-03-03 06:54:54

Yousif Capital Management LLC Sells 446 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)

Yousif Capital Management LLC lessened its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 2.4% during the fourth quarter, Holdings Channel reports. The firm owned 18,059 shares of the company’s stock after selling 446 shares during the period. Yousif Capital Management LLC’s holdings in Pacira BioSciences were worth $340,000 as of its most […] - 2025-02-18 08:49:04

China Universal Asset Management Co. Ltd. Boosts Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)

China Universal Asset Management Co. Ltd. raised its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 10.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,790 shares of the company’s stock after purchasing an additional 918 shares during the […] - 2025-02-04 09:03:01

PCRX institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	29,385	USD 696,718
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	5,905	USD 140,008
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	23,161	USD 549,147
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	23,161	USD 549,147
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	325	USD 7,706
Total =		81,937	USD 1,942,726

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer